Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: Pre-cystectomy prostate involvement as a prognostic factor

European Urology

Volumn 48, Issue 1, 2005, Pages 53-59

  Huguet, J ^a   Crego, M ^a   Sabate S ^a   Salvador, J ^a   Palou, J ^a   Villavicencio, H ^a  

^a FUNDACIÓ PUIGVERT   (Spain)

Author keywords

BCG failure; Cystectomy; Superficial bladder cancer

Indexed keywords

BCG VACCINE;

BCG VACCINATION; BLADDER CANCER; BLADDER TUMOR; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; DISEASE SEVERITY; DRUG USE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE; RETROSPECTIVE STUDY; REVIEW; SUPERFICIAL CANCER; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR RECURRENCE; URETHRA; URETHRA TUMOR; UROGENITAL ENDOSCOPY;

EID: 20544471694     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.03.021     Document Type: Article

References (29)

1. N.M. Heney Natural history of superficial bladder cancer. Prognostic features and long term disease course Urol Clin N Am 19 1992 429 433
2. V. Pansadoro, P. Emiliozzi, F. De Paula, P. Scarpone, A. Pansadoro, and C. Sternberg Long term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical Bacille Calmette-Guerin: 18-year experience Urology 59 2002 227
3. R.J. Silvester, A.P.M. Van Der Meijden, and D.L. Lamm Intravesical bacillus Calmette-Guérin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials J Urol 168 2002 1964
4. W. Oosterlink, B. Lobel, G. Jakse, P.-U. Malstrom, M. Stockle, and C. Sternberg Guidelines on bladder cancer Eur Urol 41 2002 105
5. J.A. Smith, R.F. Labasky, A.T.K. Coocket, J.A. Fracchia, J.E. Montie, and R.G. Rowland Bladder clinical guidelines pannel summary report on the management of non muscle invasive bladder cancer (stages Ta, T1 and Tis) J Urol 162 1999 1697
6. M.S. Cookson, H.W. Herr, Z.F. Zang, S. Soloway, P.C. Sogani, and W.R. Fair The treated natural history of high risk superficial bladder cancer: 15-year outcome J Urol 158 1997 62
7. J.A. Freeman, D. Ersing, J.P. Stein, A.R. Simoneau, E.C. Skinner, and S.C. Chen Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction Cancer 76 1995 833
8. G. Dalbagni, E. Genega, M. Hashibe, Z.F. Zang, P. Russo, and H. Herr Cystectomy for bladder cancer: a contemporary series J Urol 165 2001 1111
9. H. Herr, and P.C. Sogany Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166 2001 1296
10. R. Yiou, J.J. Patard, C.C. Abbou, and D.K. Chopin Outcome of radical cystectomy for bladder cancer according to the disease type at presentation BJU International 89 2002 374
11. E. Solsona, I. Iborra, R. Dumont, J. Rubio-Briones, J. Casanova, and S. Almenar The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer J Urol 164 2000 685
12. H.W. Herr, Ra. Badalament, and D.A. Amato Superficial bladder cancer treated with bacillus Calmette-Guetrin: a multivariate analysis of factors affecting tumor progression J Urol 141 1989 22
13. T.T. Buit, and P.F. Schellhammer Aditional bacillus Calmette-Guerin therapy for recurrent transitional cell carcinoma after an initial complete response Urology 49 1997 687
14. S.C. Dutta, J.A. Smith, S.B. Shappell, C.S. Coffey, S.S. Chang, and M.S. Cookson Clinical understaging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy J Urol 166 2001 490
15. S.B. Malkowicz, P. Nichols, G. Lieskovsky, S.D. Boyd, J. Huffman, and D.G. Skinner The role of radical cystectomy in the management of high stage superficial bladder cancer (PA, P1, Pis and P2) J Urol 144 1990 641
16. C.L. Amling, J.B. Thrasher, H.A. Frazier, R.K. Dodge, J.E. Robertson, and D.F.l. Paulson Radical cystectomy for stages TA, TIS and T1 transitional cell carcinoma of the bladder J Urol 151 1994 31
17. J. Huguet, J. Palou, F. Millan, H. Villavicencio, and J. Vicente Cistectomía radical en tumores superficiales en la era de la BCG Arch Esp Urol 55 2002 50
18. E. Solsona, I. Iborra, J. Rubio, J. Casanova, and S. Almenar The optimum timing of radical cystectomy for patients with recerrent high-risk superficial bladder tumor BJU International 94 2004 125
19. R. Klan, V. Loy, and H. Huland Residual tumor discovered in routine second TUR in patients with pT1 transitional cell carcinoma of the bladder J Urol 146 1991 316
20. A. Bauers, R. Buettner, and G. Jackse Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 165 2001 808
21. H.W. Herr The value of second transurethral resection in evaluating patients with bladder tumors J Urol 162 1999 74
22. D.P. Wood, J.E. Montie, J.E. Pontes, and H.S. Levin Identification of transitional cell carcinoma of the prostate in bladder cancer patients: a prospective study J Urol 142 1989 83
23. M. Donat, D.C. Wei, M.S. Mcguire, and H.W. Herr The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer J Urol 165 2001 1580
24. J. Palou, B. Xavier, P. Laguna, M. Montlleó, and J. Vicente In situ transitional cell carcinoma involvement of the prostatic urethra: bacillus Calmette-Guerin therapy without previous transurethral resection of the prostate Urology 47 1996 482
25. P.F. Shellhammer, M.A. Bean, and W.F. Whitmore Intravesical bacillus Calmette Guerin for treatment of superficial transitional cell carcinoma of the prostatic urethra in association with carcinoma of the bladder J Urol 153 1995 53
26. H.W. Herr, and S.M. Donat Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome J Urol 161 1999 1854
27. S.M. Donat, E.M. Genega, H.W. Herr, and V.E. Reuter Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance J Urol 165 2001 1117
28. D. Ersing, J.A. Freeman, D.A. Elmajian, J.P. Stein, S.C. Chen, and S. Groshen Transitional cell carcinoma involving the prostate with proposed staging classification for stromal invasion J Urol 156 1996 1071
29. E. Solsona, I. Iborra, J.V. Ricos, J.L. Monros, J.L. Casanova, and S. Almenar The prostate involvement as prognostic factor in patients with superficial bladder tumors J Urol 154 1995 1710